Vaccine Development

Oct 15, 2018
By BioPharm International Editors
The company will collaborate with GlycoBac to offer an insect cell line for the development of viral vaccines and gene therapies.
Oct 12, 2018
By BioPharm International Editors
A new investigational vaccine, LASSARAB, shows promise for use against Lassa fever and rabies.
Sep 21, 2018
By BioPharm International Editors
Research by Thermo Fisher Scientific and LumaCyte suggests that LumaCyte's Radiance instrument offers the ability to rapidly analyze viral vaccines to speed development and production and ensure their effectiveness.
Sep 06, 2018
By BioPharm International Editors
Research from the Perelman School of Medicine at the University of Pennsylvania suggests that a universal flu vaccine that protects people against most influenza strains is one step closer to reality.
Aug 27, 2018
By BioPharm International Editors
The Coalition for Epidemic Preparedness Innovations (CEPI) and vaccine manufacturer IDT Biologika will collaborate to develop and manufacture a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Aug 21, 2018
By BioPharm International Editors
Experts from the Partnership for Research on Ebola VACcination report on progress and uncertainties regarding a safe and effective Ebola vaccine.
Aug 20, 2018
By BioPharm International Editors
The National Institute of Allergy and Infectious Diseases began a first-in-human trial of an experimental live, attenuated Zika virus vaccine.
Aug 17, 2018
By BioPharm International Editors
The acquisition is expected to support Emergent BioSolutions’ focus on public health threats and emerging infectious disease.
Aug 16, 2018
By BioPharm International Editors
The companies entered a multi-year R&D collaboration to develop mRNA-based flu vaccines.
Aug 09, 2018
By BioPharm International Editors
Ebola vaccinations by the World Health Organization began in North Kivu, Democratic Republic of the Congo, one week after the country’s latest outbreak.
native1_300x100
lorem ipsum